Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Latuda, lurasidone (SM-13496)
print preview
bookmark
share with colleague
General Information
Company
Dainippon Sumitomo Pharma Co. Ltd.
Description
Small molecule antagonist of dopamine D2 receptor, serotonin (5-HT2A; 5-HT7) receptors and ADRA2C, and a partial agonist of serotonin (5-HT1A) receptor
Molecular Target
Dopamine D2 receptor
;
Adrenergic receptor alpha 2c (ADRA2C)
Mechanism of Action
Serotonin (5-HT2A) receptor antagonist
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy